Philippe Froquel

Philippe Froguel passed his Medical Degree in 1986 and he obtained a PhD in 1991 from Paris University. He is currently Professor of Genomic Medicine and head of genomics of common disease in the department of metabolism at the Hammersmith hospital, Imperial College London, UK.

He is also Professor of Endocrinology at Lille University hospital, France, director of the Inserm/CNRS/Lille-University/Pasteur Institute/University hospital of Lille UMR1283 "Functional(epi)genomics and mechanisms of type 2 diabetes and related disorders”, Director of the French laboratory of excellence on diabetes research (laBex) EGID (250 people), of the Genomics equipment of excellence in genomics (Equipex) LIGAN-personalized medicine, and of the new French National Center for Precision Medicine in diabetes PreciDIAB. 

PF's scientific carrier is focused on the genetics of diabetes and obesity. He is author of >700 Pubmed indexed publications and his H-index is 164. He is among the world most highly cited researchers (according to Clarivate HCR ranking 2019) in medical research (120K citations). Among other things, PF has identified in 1992 the first diabetes gene (glucokinase), in 1998 the most prevalent cause of monogenic obesity (MC4R), in 2007 the first gene for common obesity (FTO) and has published in 2007 the first Genome Wide Association Study (GWAS) in T2D. His current main interest is precision and personalized medicine in metabolic diseases and co morbidities.

Last updated: 22.1.2020